Dr. Thomas P. Boike, M.D.
Radiation Oncology (Radiation Oncology Physician)
- Medicare participating
At a glance
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 23
Licensed in Texas since 2010, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Radiation Oncology Physician primary
MI license 4301086290 · TX license N5580 (first issued 2010; cancelled by request)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 23
- Services billed
- 245
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 1,536 | 58 |
| Ct guidance for insertion of radiation therapy fields | 1,364 | 79 |
| Calculation of radiation therapy dose | 496 | 77 |
| Continuing radiation therapy consultation per week | 313 | 75 |
| Radiation treatment management, 5 treatment sessions | 233 | 63 |
| Established patient office or other outpatient visit, 10-19 minutes | 139 | 113 |
| Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | 77 | 12 |
| Complex radiation therapy planning | 75 | 73 |
| New patient office or other outpatient visit, 60-74 minutes | 74 | 74 |
| Cranial lesion surgery using radiation over multiple sessions | 71 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Detroit, MI | 20 |
| Orgovyx (relugolix) | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,500 in research payments for these studies, mostly to the institutions running them.
- A randomized phase ii trial of salvage radiotherapy with standard vs enhanced androgen deprivation therapy with enzalutamide in patients with postprostatectomy psa recurrences with aggressive disease features
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.